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Telomeres are specialized nucleoprotein struc-
tures at the ends of linear chromosomes that 
protect chromosomal DNA from degradation, 
rearrangement, and detrimental fusion events 
(1). The ribonucleoprotein enzyme complex 
telomerase maintains telomeres by adding mul-
tiple hexameric repeats (TTAGGG)n to the end 
of chromosomes. Telomerase consists of two 
essential core components: telomerase reverse 
transcriptase (TERT) and a telomerase RNA 
(TR) that serves as the template for TERT (2). 
Vertebrate TRs have conserved secondary 
structures comprised of four structural domains: 
the pseudoknot (core) domain, the conserved 
region (CR)4 and 5 (CR4-5) domain, the 
boxH/ACA domain, and the CR7 domain 
(3). The pseudoknot domain contains the tem-
plate region for synthesis of complementary 
DNA and is essential for stable assembly with 
TERT. The CR4-5 domain supports catalytic 
telomerase activity by enhancing the proces-
sivity of nucleotide addition. The boxH/ACA 
domain and the CR7 domain are essential for 
TR   stability (3–5).
Telomerase activity is diminished in most 
somatic cells but commonly up-regulated in 
immortalized and cancer cells (6, 7). Unlike 
TERT, whose expression correlates with telo-
merase activity, TR is constitutively expressed 
in somatic cells (8); however, generally, cancer 
cells have elevated levels of TR. It has been 
speculated that telomere maintenance is neces-
sary for unlimited cancer cell proliferation, but 
recent studies suggest that telomerase can pro-
mote tumorigenesis independently of telomere 
elongation (9–11).
Marek’s disease (MD) is a fatal neoplastic 
disease of chickens caused by a lymphotropic 
alphaherpesvirus, MD virus (MDV). MD is 
characterized by neurological disorders,   immune 
defi  ciency, and malignant T cell lymphomas 
that form as early as 12–14 d after infection (12). 
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a reverse transcriptase and an RNA subunit (telomerase RNA [TR]). Dysregulation of telom-
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  induced T cell lymphomagenesis. Furthermore, our results provide the fi  rst description of 
tumor-  promoting effects of TR in a natural virus–host infection model.
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MDV-transformed T cells and lymphoblastoid cell lines de-
rived from primary lymphomas regularly harbor integrated 
viral genomes (13, 14). The rapid onset of virus-induced 
lymphoma suggests a direct involvement of virus-encoded 
oncogenes in MD tumorigenesis. The MDV Meq protein, 
a member of the Jun/Fos oncoprotein family, has been exten-
sively characterized (15–17). Infection studies with a mutant 
MDV suggest that meq is the principal MDV oncogene (18, 19). 
Other viral genes, however, are suspected to serve important 
functions in MD tumorigenesis because Meq has only weak 
oncogenic potential in primary chicken cells (15).
MDV harbors in its genome a viral homologue of TR, 
termed viral TR (vTR), which exhibits 88% sequence iden-
tity to chicken TR (chTR) and was likely pirated from the 
chicken genome (20). The MDV genome is a 180-kbp 
double-stranded linear DNA consisting of two unique se-
quences, a long (unique-long [UL]) and a short (unique-
short [US]), each of which is bracketed by inverted internal 
(IRL, IRS) and terminal repeats (TRL, TRS; see Fig. 1 A). 
vTR is located in the TRL and IRL regions (see Fig. 1 B), 
and, consequently, two copies of vTR are present in the 
MDV genome. The four generic structural TR domains 
consisting of eight CRs are globally conserved in the vTR 
sequence (see Fig. 1 C). Compared with chTR, however, 
vTR exhibits several point mutations and deletions (20, 21), 
which are mainly located in the junction regions outside of 
the conserved structural domains, more specifi  cally those of 
the pseudoknot domain (20, 22). Functional analyses have 
shown that vTR can reconstitute telomerase activity by in-
teracting with TERT more effi   ciently than chTR (20, 21). 
The increased effi   ciency of vTR over chTR could be attri-
buted to mutations aff  ecting the pseudoknot core domain, 
likely by stabilization of the pseudoknot P2 helix (21). 
It is also notable that a single nucleotide substitution in the 
boxH region, which is present in the nononcogenic MDV 
vaccine strain CVI988, results in a substantial loss of function-
ality of vTR (21).
In this study, we aimed to elucidate the role of vTR in 
MDV-induced lymphomagenesis. Based on an infectious 
clone of the highly oncogenic MDV strain RB-1B (23), mu-
tant MDV with functional deletions of either one or both 
copies of the diploid vTR gene were generated. Pathogenesis 
studies in chickens clearly showed that vTR is dispensable 
for early cytolytic replication but is required for effi   cient in-
duction of T cell malignancies. Lymphoma incidences were 
drastically reduced in birds inoculated with mutant viruses 
lacking both copies of vTR when compared with parental 
virus or viruses with a deletion of only one copy of vTR. 
Lymphomas induced by the vTR double deletion viruses 
were signifi  cantly less disseminated and generally smaller in 
size than those induced by the parental virus or vTR single 
deletion viruses. Revertant viruses in which both copies of 
the previously deleted vTR gene were repaired showed on-
cogenic properties identical to those of the parental virus, 
confi  rming that vTR is required for effi   cient MDV-induced 
lymphomagenesis. Finally, we were able to show that vTR-
overexpressing DF-1 cells exhibited characteristics of trans-
formation. In summary, our results demonstrate that vTR 
plays an important role in MDV-induced malignant T cell 
lymphomagenesis and in promoting tumor dissemination, 
and provide further evidence that TR exhibits a pivotal func-
tion in telomerase-associated tumorigenesis.
RESULTS
Construction of MDV bacterial artifi  cial chromosome 
(BAC) mutants
MDV mutants with a functional deletion of either one or 
both copies of the diploid vTR gene were generated from 
pRB-1B, an infectious BAC clone of the highly oncogenic 
MDV strain RB-1B (23). To generate vTR single deletion 
BAC mutants, pCR1-2+/− and pCR1-4+/−, sequences 
encoding vTR, or more specifi  cally the functionally essen-
tial CR1-2 or CR1-4, were deleted from the IRL region 
of pRB-1B by Red mutagenesis (Fig. 1 B and Fig. S1 A, 
which is available at http://www.jem.org/cgi/content/full/
jem.20052240/DC1). Mutant pCR1-2−/− and pCR1-4−/−, 
in which both copies of the vTR gene in the IRL and TRL 
regions were disrupted by deletion of CR1-2 or CR1-4, 
  respectively, were generated by two consecutive steps of Red 
mutagenesis and FLP recombination (24). FLP recombina-
tion resulted in removal of the previously introduced ka-
namycin-resistance gene (Fig. S1 A). Revertant genomes 
pCR1-2−/−R1 and pCR1-2−/−R2 from the pCR1-2−/− 
double deletion mutant were generated by a recently de-
veloped protocol using two-step Red mutagenesis that al-
lows for markerless manipulation of BAC DNA (Fig. S1 B; 
reference 25). Genomic DNA of the generated mutant and 
revertant genomes was analyzed by PCR and by restriction 
fragment length polymorphism determination using BamHI 
digestion followed by Southern blotting using a vTR-specifi  c 
probe. We confi  rmed that the expected genomic changes 
were present in the respective BACs and that no spurious 
rearrangements occurred during the genetic manipulations 
(Fig. 1, D and E).
vTR is expressed during lytic and latent MDV infection 
but is dispensable for MDV replication in vitro
To confi  rm that vTR is expressed during lytic virus infection 
and latency, total RNA was extracted from RB-1B–infected 
primary chicken embryo cells (CECs) or an RB-1B–trans-
formed lymphoblastoid cell line (MDCC-UD14; reference 
26), and RT-PCR was performed. Expression of vTR was 
detected in RB-1B–infected CECs and MDCC-UD14, but 
not in uninfected CECs or a retrovirus-transformed lympho-
blastoid cell line (RECC-CU91; reference 27), which were 
used as controls (Fig. 2).
To assess growth properties of the generated recombinant 
viruses, parental vRB-1B and vTR mutant viruses, termed 
vCR1-2+/−, vCR1-4+/−, vCR1-2−/−, and vCR1-4−/−, 
were reconstituted from BAC DNA by transfection (28) and 
propagated on primary CECs. The in vitro replication prop-
erties of the mutant viruses were determined by analyzing JEM VOL. 203, May 15, 2006  1309
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multistep growth kinetics and plaque sizes. Growth kinetics 
of all mutant viruses were virtually indistinguishable from 
those of parental vRB-1B (Fig. 3 A). Plaques induced by 
vTR− mutant viruses vCR1-2−/− and vCR1-4−/− were 
slightly, albeit insignifi  cantly, smaller than those induced by 
vRB-1B or mutant viruses in which only one vTR copy was 
functionally deleted (vCR1-2+/− and vCR1-4+/−; Fig. 3 B). 
The data clearly demonstrated that vTR is dispensable for 
lytic MDV replication in vitro and that no substantial growth 
defect in the absence of functional vTR was observed.
vTR is dispensable for effi  cient lytic MDV replication in vivo
In the next series of experiments, the growth properties of 
mutant MDV in chickens were assessed. To determine the 
Figure 1.  Genomic structure of vTR deletion and revertant viruses. 
(A) Schematic presentation of the genomic organization and the BamHI 
restriction map of MDV. The terminal and internal repeat long regions 
(TRL, IRL), the unique long region (UL), the internal and terminal repeat 
short regions (IRS, TRS), and the unique short region (US) are shown. 
(B) Schematic presentation of the MDV BamHI-L fragment and the genes 
located therein. The parental (vRB-1B) and mutant viruses lacking either 
one (vCR1-2+/−, vCR1-4+/−) or both copies of vTR (vCR1-2−/−, vCR1-
4−/−) are shown. BamHI restriction sites are given. (C) Detailed schematic 
presentation of the vTR gene and the putative ICP0 ortholog. The eight 
CRs of vTR are given in black. Deletion of CRs 1 and 2 (∆CR1-2) or 1 to 4 
(∆CR1-4) in the genome of vTR mutant viruses is indicated. Also shown is 
the location of sequences contained in the Southern blot probe. 
(D) Southern blot analysis of mutant MDV BACs. DNA of pRB-1B and 
mutant MDV BACs (pCR1-2+/−, pCR1-2−/−, pCR1-4+/−, pCR1-4−/−, and 
pCR1-2−/−R1) was prepared, digested with BamHI, and separated on a 
0.8% agarose gel. Southern blot analysis was performed using a PCR-
generated digoxigenin-labeled probe using oligonucleotide primers vTRfw 
5′-T G G C G G G T G G A A G G C -3′ and vTRrv 5′-C T G C G G G C G A G G A C C -3′. 
  Fragments detected by the vTR probe are indicated by asterisks, and sizes 
are given. (E) PCR analysis of the mutant BACs. vTR-specifi  c sequences 
were amplifi  ed by using oligonucleotide primers vTRfw and vTRrv, and 
amplifi  cation products were separated on a 1% agarose gel. The size of 
the specifi  c PCR product is given.1310  VIRAL TELOMERASE RNA IMPACTS LYMPHOMA MALIGNANCY | Trapp et al.
extent of lytic virus replication in the natural host, 1-d-old 
chickens were infected with either vRB-1B, vCR1-2+/−, 
vCR1-4+/−, vCR1-2−/−, or vCR1-4−/−. Whole blood 
samples were collected on 4, 7, 12, 15, 19, and 30 d after in-
fection from all chickens of each group infected with the 
various viruses. Copy numbers of viral genomes were deter-
mined by quantitative real-time PCR (qPCR) amplifi  cation 
of a viral gene (gD) and normalized to chicken genome cop-
ies by the determination of the number of inducible nitric 
oxide synthetase (iNOS) copies (29). All viruses induced 
very similar levels of viremia until 15 d after infection, indi-
cating that vTR is completely dispensable for the early cyto-
lytic phase of MDV replication in vivo (Fig. 4). At 19 d after 
infection, viremia levels were higher in birds infected with 
vRB-1B, vCR1-2+/−, or vCR1-4+/− when compared with 
those of birds infected with the vTR double deletion mu-
tants. The diff  erences, however, were not statistically signifi  -
cant and leveled off   later in infection at 30 d after infection 
when virtually identical numbers of viral genome copies 
were detected in peripheral blood in all groups by qPCR 
(Fig. 4). From the results, we concluded that vTR is dispens-
able for lytic replication in vivo and that only minimal diff  er-
ences in normalized viral genome copy numbers were 
detected in chickens infected with either parental or vTR 
mutant viruses. In addition, the data clearly showed that vTR 
is also dispensable for the establishment of latency because 
sustained presence of MDV genomes in peripheral blood was 
observed >8 d after infection when MDV enters the latent 
state of infection (12).
vTR is required for effi  cient MDV-induced lymphomagenesis
To determine whether vTR plays a role in MDV-induced 
lymphomagenesis, 1-d-old chickens were infected with pa-
rental or mutant viruses. Infected animals were monitored for 
development of disease, which is characterized by chronic 
wasting, paralysis, and lymphoma development, as well as 
mortality. Necropsied birds were scored for lymphoma inci-
dence and dissemination, and the results of three independent 
animal experiments are summarized in Fig. 5. Signifi  cantly 
Figure 2.  Expression of vTR in lytically infected CECs and latently 
infected and transformed lymphoma cells. An RT-PCR analysis of total 
RNA (2 μg) extracted from RB-1B–infected CECs or uninfected cells, as 
well as from lymphoblastoid cell lines RECC-CU91 and MDCC-UD14, is 
shown. RECC-CU91 is a lymphoblastoid cell line transformed by a retrovi-
rus, reticuloendotheliosis virus. MDCC-UD14 is a T cell lymphoma cell line 
isolated from an RB-1B–infected bird. RT-PCR was performed using oli-
gonucleotide primers, vTR(exp)fw 5′-G G C A C A C G T G G C G G G T G G A A G G -3′ 
and vTR(exp)Arv 5′-C A G T G C T G C G C C G A T T C T A C -3′.
Figure 3.  Growth properties in vitro of mutant viruses demonstrat-
ing that vTR is dispensable for MDV replication in vitro. (A) Growth 
kinetics of the indicated viruses. 106 CECs were infected with 100 PFU of 
vRB-1B or vTR mutant viruses. At the indicated times after infection, in-
fected cells were dissociated by trypsinization and virus titers were deter-
mined by plating serial 10-fold dilutions of infected cells onto fresh CECs. 
Means and standard deviations (error bars) of three independent experi-
ments are given. (B) Relative plaque sizes induced by the indicated 
  viruses. Plaque areas were measured 7 d after infection after fi  xing cells 
with 90% acetone and performing indirect immunofl  uorescence using a 
convalescent MDV-specifi  c chicken serum and Alexa Fluor 488 goat anti–
chicken IgG (Invitrogen). For each virus, 100 randomly selected plaques 
were photographed with a digital camera (Zeiss Axiovert 25 and Axiocam; 
Carl Zeiss MicroImaging, Inc.), and plaque areas were determined using 
ImageJ software. Means and standard deviations (error bars) are given.
Figure 4.  vTR is dispensable for lytic MDV replication in vivo and 
for the establishment of latency. A qPCR analysis of the viral gD gene 
and a host gene (iNOS) in total DNA isolated from whole blood samples, 
which were taken at days 4, 7, 12, 15, 19, and 30 after infection from 
virus-infected chickens, is shown. Mean viral load values and standard 
deviations (error bars) are given as copies of gD per 106 copies of chicken 
iNOS. No statistically signifi  cant differences in viremia levels were ob-
served between groups infected with vTR single and double deletion vi-
ruses or parental vRB-1B.JEM VOL. 203, May 15, 2006  1311
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reduced incidences of MD were observed in groups infected 
with the vTR double deletion mutants vCR1-2−/− (57.8%) 
and vCR1-4−/− (59.7%), relative to groups infected with 
vRB-1B (88.1%) or either of the vTR single deletion mutants 
(vCR1-2+/−, 89.4%; vCR1-4+/−, 88.0%; Fig. 5 A). As ex-
pected, no clinical or pathological signs of MD were observed 
in mock-infected birds used as a negative control in experi-
ment 1 (not depicted). All animals infected with vRB-1B, 
vCR1-2+/−, or vCR1-4+/− that developed MD also showed 
lymphoma development. In stark contrast, in both the vCR1-
2−/− and vCR1-4−/− groups, some of the birds that pre-
sented with clinical signs of MD, such as neurological signs, 
reduced weight gain, and wasting, did not develop cancerous 
lesions. Accordingly, only 36.1 and 39.3% of birds infected 
with vCR1-2−/− and vCR1-4−/−, respectively, developed 
lymphomas compared with 88.1, 89.4, and 88.0% of birds 
infected with vRB-1B, vCR1-2+/−, or vCR1-4+/− (Fig. 5 B). 
Furthermore, lymphomas induced by viruses harboring at 
least one intact copy of vTR predominantly disseminated to 
multiple organ sites, whereas the majority of lesions induced 
by vCR1-2−/− and vCR1-4−/− aff  ected no more than two 
organs (Fig. 5 C and Fig. S3, which is available at http://
www.jem.org/cgi/content/full/jem.20052240/DC1). Gen-
erally, lesions induced by vCR1-2−/− and vCR1-4−/− were 
considerably smaller than those induced by vRB-1B, vCR1-
2+/−, or vCR1-4+/− (Fig. S3).
To confi  rm that the observed phenotype of the vTR− 
viruses, characterized by a reduction in lymphoma incidence 
and dissemination, was actually caused by the functional 
deletion of vTR, oncogenic properties of two indepen-
dently isolated revertant viruses in which both copies of 
vTR were repaired to parental sequences were investigated. 
  Oncogenicity of revertant viruses vCR1-2−/−R1 and vCR1-
2−/−R2 was assessed in an additional animal experiment and 
compared with parental vRB-1B as well as the respective 
CR1-2 single and double deletion mutants, vCR1-2+/− and 
vCR1-2−/−. The results of the experiment clearly dem-
onstrated that both revertant viruses were indistinguishable 
from parental vRB-1B virus with respect to viremia levels 
as well as lymphoma incidence and dissemination (Fig. 6 
and Fig. S2, which is available at http://www.jem.org/cgi/
content/full/jem.20052240/DC1).
Collectively, the results of the animal experiments clearly 
demonstrated that expression of vTR is critical for effi   cient 
MDV-induced T cell lymphomagenesis and substantially pro-
motes invasiveness of MD lymphomas.
Figure 5.  Mutant viruses lacking both copies of vTR are attenu-
ated and severely impaired in their ability to induce lymphoma. In 
three independent experiments, chickens were inoculated with 500 
PFUs of vRB-1B or vTR mutant viruses. During the course of the experi-
ments, moribund birds were killed and necropsied. After a 9-wk obser-
vation period, all surviving birds were necropsied and evaluated for MD. 
Morbidity and lymphoma incidences were recorded. (A) MD incidence 
(percentage of birds showing clinical symptoms and/or lymphomatous 
lesions) in animal groups infected with the indicated viruses. Means 
and standard deviations (error bars) are given. The decreased MD inci-
dences observed in animal groups infected with vCR1-2−/− and vCR1-
4−/− relative to groups infected with vRB-1B, vCR1-2+/−, or vCR1-4+/− 
were statistically signifi  cant (*) as follows: vRB-1B versus vCR1-2−/−, 
P = 0.0117; vRB-1B versus vCR1-4−/−, P = 0.0117; vCR1-2+/− versus 
vCR1-2−/−, P = 0.0055; vCR1-2+/− versus vCR1-4−/−, P = 0.0055; 
vCR1-4+/− versus vCR1-2−/−, P = 0.0055; vCR1-4+/− versus vCR1-
4−/−, P = 0.0055. (B) Lymphoma incidences (percentage of birds show-
ing lymphomatous lesions) in groups infected with the indicated 
viruses are given as means and standard deviations (error bars). The 
decreased lymphoma incidences detected in groups infected with 
vCR1-2−/− and vCR1-4−/− relative to groups infected with vRB-1B, 
vCR1-2+/−, or vCR1-4+/− were statistically signifi  cant (*) as follows: 
vRB-1B versus vCR1-2−/−, P = 0.0117; vRB-1B versus vCR1-4−/−, 
P = 0.0117; vCR1-2+/− versus vCR1-2−/−, P = 0.0055; vCR1-2+/− ver-
sus vCR1-4−/−, P = 0.0055; vCR1-4+/− versus vCR1-2−/−, P = 0.0055; 
vCR1-4+/− versus vCR1-4−/−, P = 0.0055. (C) Lymphomas induced by 
mutant viruses lacking both copies of vTR have an altered dissemina-
tion pattern within individual chickens. Organ manifestations of 
  lymphomatous lesions in individual birds were recorded in three 
  independent animal experiments, and percentages are given of birds 
infected with the indicated viruses, which failed to develop lymphoma 
(0) or in which less than or more than two sites of lymphoma manifes-
tation were observed. Means and standard deviations (error bars) are 
given. The reduced disseminations of lymphomas detected in groups 
infected with vCR1-2−/− and vCR1-4−/− relative to groups infected 
with vRB-1B, vCR1-2+/− or vCR1-4+/− were statistically signifi  cant 
(*) as follows: vRB-1B versus vCR1-2−/−, P = 0.0025; vRB-1B versus 
vCR1-4−/−, P = 0.0033; vCR1-2+/− versus vCR1-2−/−, P = 0.0022; 
vCR1-2+/− versus vCR1-4−/−, P = 0.0029; vCR1-4+/− versus vCR1-
2−/−, P = 0.0143; vCR1-4+/− versus vCR1-4−/−, P = 0.0188.1312  VIRAL TELOMERASE RNA IMPACTS LYMPHOMA MALIGNANCY | Trapp et al.
DF-1 cells overexpressing vTR exhibit a partially 
transformed phenotype
The results of the animal experiments led us to explore the 
transforming potential of vTR in vitro. A DF-1–based cell 
line constitutively overexpressing vTR (DF-1vTR) was gen-
erated. Growth characteristics of DF-1vTR were analyzed 
and compared with those of a vector control cell line (DF-
1vector) and a cell line constitutively expressing Meq (DF-
1Meq). The DF-1Meq cell line was used as a positive control 
because the Meq oncoprotein was shown to possess trans-
forming and mitogenic properties (15, 19, 30).
First, growth rates of the diff  erent recombinant cell lines 
were determined (Fig. 7 A). Until 72 h after seeding, DF-
1Meq cells showed the highest population doubling levels of 
all three cell lines analyzed. At 96, 120, and 144 h after seed-
ing, however, DF-1vTR cells exhibited the highest popula-
tion doubling levels, and cells overexpressing vTR grew to a 
signifi  cantly higher saturation density than both DF-1vector 
and DF-1Meq cells. Compared with DF-1vTR, saturation 
densities of DF-1vector and DF-1Meq cells were reduced by 
38 and 7%, respectively.
Second, soft agar colony formation assays were performed 
(Fig. 7, B and C). All three cell lines were able to form colo-
nies in nutrient agar with the same cloning effi   ciency of  3% 
(Fig. 7 B). Expression of Meq resulted in signifi  cantly en-
larged soft agar colonies, which have been described (15, 19), 
and average colony sizes formed by DF-1Meq cells were in-
creased by 64.6% relative to those formed by DF-1vector 
(Fig. 7 C). Similarly, DF-1vTR cells formed signifi  cantly en-
larged colonies (21.2%) when compared with those formed 
by the DF-1vector cells (Fig. 7 C).
Third, morphological phenotypes of DF-1vector, DF-
1vTR, and DF-1Meq cells were analyzed by phase contrast 
microscopy. Overexpression of vTR in DF-1vTR cells was 
accompanied by clearly identifi  able changes in cellular mor-
phology toward a more refractile and spindle-shaped pheno-
type as compared with DF-1vector cells. These morphological 
alterations of DF-1vTR cells were very similar to those seen 
in DF-1Meq cells (Fig. 7 D).
We also asked whether vTR overexpression would result 
in up-regulation of telomerase activity, resulting in altered 
telomere lengths in DF-1vTR cells. Terminal restriction 
fragment lengths of chromosomal DNA prepared from DF-
1vector, DF-1vTR, and DF-1Meq cells were compared by 
Southern blot hybridization using a telomere-specifi  c probe. 
The results of the terminal restriction fragment analysis 
clearly indicated that the lengths of telomeres in these diff  er-
ent cell lines were indistinguishable from one another (Fig. 
S4 C, available at http://www.jem.org/cgi/content/full/
jem.20052240/DC1). Prompted by a recent report suggest-
ing that TR may have a malignancy-promoting function me-
diated by the up-regulation of integrin αv (31), we examined 
expression of this cell adhesion receptor molecule and that 
of MHC class I as a control in the generated DF-1vTR cell 
line. On average, integrin αv expression was twofold higher 
(range: 1.55- to 2.69-fold in three independent experiments) 
in DF-1vTR cells relative to DF-1vector or DF-1Meq cells 
(Fig. 7 E). In contrast, MHC class I expression was virtu-
ally identical in DF-1vTR and DF-1vector cells, whereas 
it was up-regulated 1.84-fold (range: 1.68- to 1.94-fold) in 
Meq-expressing cells when compared with DF-1vector or 
DF-1vTR cells (Fig. 7 E). These latter results are in agree-
ment with microarray data of an independently generated 
DF-1Meq cell line for which up-regulation of MHC class I 
transcription was reported (19).
From the results of the cell proliferation and soft agar col-
ony formation assays as well as the examination of cellular 
morphologies, we concluded that MDV vTR is clearly able 
to promote cell growth, induces increased levels of integrin 
αv expression, and exhibits a potential for transformation, 
which is comparable to that of the MDV Meq oncoprotein.
DISCUSSION
Telomerase activity is strongly correlated with cancer devel-
opment and implicated in the process of cellular immortaliza-
tion and oncogenesis. An association of TR up-regulation 
and malignancy has been described in several reports (32–34). 
Recently, it was shown that TR is required for the tumor-
promoting eff  ects of TERT overexpression (35), and that RNAi-
mediated depletion of TR is eff  ective in inhibiting cancer cell 
growth independently of its function in maintaining telomere 
Figure 6.  Lymphoma incidences (A) and dissemination patterns 
(B) in chickens infected with parental, vTR mutant, and vTR rever-
tant viruses. Lymphoma incidences are given as the percentage of birds 
having lymphomatous lesions. Dissemination patterns are shown as the 
percentages of birds that failed to develop lymphoma (0) or in which less 
than or more than two sites of lymphoma manifestation were observed. 
The decreased lymphoma incidence detected in groups infected with 
vCR1-2−/− relative to groups infected with vRB-1B, vCR1-2+/−, vCR1-
2−/−R1, or vCR1-2−/−R2 were statistically signifi  cant (*) as follows: 
vCR1-2−/− versus vRB-1B, P = 0.0361; vCR1-2−/− versus vCR1-2+/−, 
P = 0.0453; vCR1-2−/− versus vCR1-2−/−R1, P = 0.0361; vCR1-2−/− 
versus CR1-2−/−R1, P = 0.0094.JEM VOL. 203, May 15, 2006  1313
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length (31, 36). A direct involvement of TR in tumorigenesis, 
however, has not yet been reported. Here we describe a criti-
cal role for a virus-encoded TR in malignant T cell lym-
phomagenesis induced by the herpesvirus MDV. This, to our 
knowledge, is the fi  rst evidence for tumor-promoting eff  ects 
of TR activity in a natural small animal model.
Figure 7.  DF-1 cells overexpressing vTR exhibit a partially trans-
formed phenotype and elevated integrin 𝗂v expression levels. 
(A) Growth rates of DF-1vector, DF-1vTR, and DF-1Meq cell lines. Cells 
were seeded in duplicate at a density of 105 in 12-well dishes. At 8, 24, 48, 
72, 96, 120, and 144 h after plating, cells were trypsinized and viable cells 
were counted using a hemocytometer. Means and standard deviations 
(error bars) of three independent experiments are given. At 144 h after 
plating, the average numbers of viable cells of the different recombinant 
cell lines were statistically signifi  cantly different as follows: DF-1vector 
versus DF-1vTR, P < 0.0001; DF-1vector versus DF-1Meq, P < 0.0001; DF-
1vTR versus DF-1Meq, P = 0.0155. (B) Anchorage-independent growth of 
DF-1vector, DF-1vTR, and DF-1Meq cells in soft agar as determined by 
colony formation after 4 wk of incubation at 37°C. The cloning effi  ciencies 
(percentages of cells forming colonies after 3 wk) of the indicated cell 
lines are shown. Means and standard deviations (error bars) of three inde-
pendent experiments are given. No statistically signifi  cant differences in 
cloning effi  ciencies between the cell lines were observed. (C) Relative sizes 
of soft agar colonies formed by DF-1vector, DF-1vTR, and DF-1Meq. For 
each of the indicated cell lines, 100 randomly selected colonies were pho-
tographed with a digital camera and colony diameters were determined 
using ImageJ software. Means and standard deviations (error bars) are 
given. The average colony sizes formed by DF-1vector, DF-1vTR, and DF-
1Meq cells were statistically signifi  cantly different as follows: DF-1vector 
versus DF-1vTR, P = 0.0021; DF-1vector versus DF-1Meq, P < 0.0001; DF-
1vTR versus DF-1Meq, P = 0.0007. (D) Morphological phenotypes of DF-
1vector, DF-1vTR, and DF-1Meq cells photographed under an inverted 
microscope (Zeiss Axiovert 25; Carl Zeiss MicroImaging, Inc.). Bar, 50 μm. 
(E) Integrin αv expression was higher in DF-1vTR relative to DF-1vector or 
DF-1Meq cells, whereas MHC class I expression was up-regulated in DF-
1Meq cells. Cell lines were trypsinized and incubated with a mixture of a 
1:2,000 dilution of a rabbit polyclonal antibody directed against integrin 
αv (Chemicon) and a 1:200 dilution of anti–chicken MHC class I monoclo-
nal antibody C6B12 (Developmental Study Hybridoma Bank, University of 
Iowa). The secondary antibodies used were anti–rabbit IgG Alexa 488 (In-
vitrogen) and anti–mouse IgG Cy5 (Jackson ImmunoResearch Labora-
tories), used at 1:200 dilutions, respectively. Cells were examined using 
FACScan (Becton Dickinson), and data were analyzed using FlowJo, version 
5.7.2 for Windows (Tree Star). A representative experiment of integrin αv 
expression (left) and MHC class I expression (middle) is shown. Means and 
standard deviations of mean channel of fl  uorescence ratios of integrin αv 
and MHC class I expression of DF-1vTR and DF-1Meq cells relative to DF-1 
vector cells of three independent experiments are also given (right).1314  VIRAL TELOMERASE RNA IMPACTS LYMPHOMA MALIGNANCY | Trapp et al.
Four diff  erent mutant MDVs lacking either one or both 
copies of the diploid vTR gene showed virtually no defect in 
viral replication in vitro when compared with parental virus. 
We also discovered that vTR is completely dispensable for 
the early lytic phase of viral replication in the natural chicken 
host. MDV infection switches from the cytolytic to latent 
phase from around 8 d after infection (12). Because parental 
and mutant viruses replicated to similar levels until at least 
15 d after infection, our data clearly indicate that vTR is dis-
pensable not only for early lytic replication of MDV, but also 
for establishment of latency, an essential prerequisite for 
MDV-induced transformation and lymphomagenesis. A trend 
of higher levels of viral genomic copy numbers was ob-
served in birds infected with the parental virus compared 
with those infected with vTR double deletion viruses at 19 d 
after infection. Although the diff  erences were not statistically 
signifi  cant, the lower MDV copy numbers may refl  ect a dif-
ference in the number of transformed T cells between ani-
mals that were inoculated with vTR+ or vTR− viruses. 
MDV-induced transformation of T cells results in massive 
proliferation between 14 and 20 d after infection. Viremia 
levels induced by all fi  ve viruses tested were very similar at 30 d 
after infection. This fi  nding seems to suggest that absence of 
vTR does not result in signifi  cantly reduced T cell prolifer-
ation; however, it is known that the later phases of MDV 
  infection are characterized by alternating stages of latent 
  infection and reactivation, and the detection of relatively 
high viral genome numbers in birds infected with the vTR− 
viruses may refl  ect lytic replication. This latter interpretation 
is supported by the fact that birds in these groups—although 
clearly less affl   icted by lymphoma formation and particularly 
tumor dissemination—still developed MD characterized by 
immunosuppression and chronic wasting that is associated 
with lytic destruction of B and T lymphocytes by reactivated 
virus (12). Collectively, the data clearly indicate that the tu-
mor-promoting eff  ects of vTR expression cannot be attrib-
uted to a functional role in MDV replication per se, or in the 
establishment or reactivation from latency, but are caused by 
events downstream of primary establishment of infection.
Although lytic virus replication and entry of the latent 
state did not seem grossly aff  ected in the absence of vTR, 
mutant viruses lacking both copies of either CR1 and CR2 
or CR1 to CR4 of vTR were signifi  cantly impaired in their 
ability to induce lymphoma and displayed a virtually identi-
cal phenotype in vivo. This fi  nding is remarkable because 
deletion of the CR1 to CR4 in the vCR1-4−/− mutant 
also   aff  ected the 3′ end of a predicted open reading frame 
(R-LORF1, MDV002), which shares homology to herpes-
viral ICP0 orthologs. Therefore, the putative MDV ICP0 
ortholog, if expressed, is not required for virus lytic replication 
and reactivation from latency, functions for which ICP0 pro-
teins of other herpesviruses are essential (37–39).
Lymphoma incidences were reduced by  60% in the 
case of the double deletion viruses, but the number of birds 
with MD symptoms was only reduced by  40% compared 
with groups infected with viruses that still expressed one in-
tact copy of vTR. MD in chickens can develop without for-
mation of lymphoma, which was in fact associated with the 
disease syndrome only >20 yr after the fi  rst description of the 
disease (40, 41). Impaired lymphoma formation in animals 
infected with vTR− viruses in the presence of unabated lytic 
and latent infection strongly suggests a direct role for vTR in 
MDV-induced lymphomagenesis.
A functional telomerase complex consisting of vTR and 
chicken TERT was shown to have threefold enhanced telo-
mere amplifi  cation activity over the chTR–chicken TERT 
complex (21). It is therefore possible that the tumor-promot-
ing function of vTR is linked to its ability to form a func-
tional telomerase complex with chicken TERT. It was also 
shown, however, that telomere elongation is not an absolute 
requirement for tumor formation in some cases and that acti-
vation of telomerase can promote tumorigenesis indepen-
dently of this function of telomerase (9–11). We currently 
favor a model in which the lymphomagenic activity of vTR 
is independent of telomere length for the following main 
reasons. First, MDV infects young birds and causes tumors 
starting from 14 d after infection when the condition of telo-
meres should not be a factor for cell survival. Second, telom-
erase is commonly up-regulated in activated T cells, which 
are the target for MDV-induced oncogenic transformation 
(42–44). Third, we did not observe obviously altered telo-
mere lengths either in birds infected with the vTR− viruses at 
later times after infection (unpublished data) or in DF-1vTR 
cells constitutively expressing vTR (Fig. S4 C). It is worth-
while to note in this context that it was recently described 
that expression of TR is vital for the tumor-promoting 
eff  ects of TERT overexpression independent of telomere 
maintenance (35). In a murine skin tumorigenesis model, 
mice overexpressing TERT in a TR− background (K5-
TERT/TERC−/−) were signifi  cantly impaired in their abil-
ity to develop papillomas (35). Moreover, the size and 
number of cancerous lesions per animal were signifi  cantly 
reduced in TR knockout mice when compared with TR-
expressing K5-TERT mice (35). These fi   ndings are fully 
consistent with our results on the incidence, dissemination, 
and size of tumors induced by MDV that are unable to ex-
press vTR. Lymphomas caused by VTR− viruses exhibited 
signifi  cantly reduced dissemination compared with that in-
duced by VTR+ viruses. Furthermore, we found that neo-
plastic lesions induced by the latter viruses were more 
pronounced than those induced in the absence of vTR.
A positive correlation between TR expression and can-
cer malignancy has been reported in numerous clinical stud-
ies (32–34, 45), and TR expression levels are considered a 
valuable diagnostic and prognostic marker in clinical oncol-
ogy (46, 47). Although a direct causal connection between 
TR expression and cancer malignancy is not yet conclusively 
established, our data in the MDV-chicken model clearly in-
dicate that aggressiveness of MDV-induced lymphomas is 
closely related to a functional role of TR in promoting 
  lymphoma dissemination and cancer cell growth. One possi-
ble mechanistic explanation of the modulation of tumor JEM VOL. 203, May 15, 2006  1315
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  dissemination by (v)TR may be the up-regulation of integ-
rin αv expression, which is an important factor in progres-
sion and metastasis of several diff  erent malignancies (48). We 
were able to establish a link between MDV vTR and integ-
rin αv expression by demonstrating increased levels of the 
protein in a vTR-expressing cell line. These results, in the 
context of fi  ndings in EBV-transformed lymphomblastoid 
cell lines in which latent gene products were shown to trans-
activate integrin αv promoters and up-regulate expression 
(49), may indicate that cell adhesion receptors containing 
this particular α subunit are important for lymphomagenesis, 
more specifi   cally for dissemination and homing of trans-
formed lymphocytes. It was also demonstrated that RNAi-
mediated TR knockdown induced decreased expression 
levels of cyclin G2 and integrin αv, and resulted in a rapid 
inhibition of cancer cell growth (31). In future studies, we 
will seek to corroborate the fi  ndings of vTR-mediated up-
regulation of integrin αv by examination of peripheral blood 
mononuclear cells and lymphoma cells derived from animals 
infected with the various vTR mutant viruses and elucidate 
the signaling pathways involved in this putative function of 
MDV-encoded vTR.
Our observation that vTR is directly involved in T cell 
lymphomagenesis as well as the spread and homing of trans-
formed cells was further supported by data on the growth-
promoting eff  ects of vTR in DF-1 cells in vitro. DF-1 is a 
continuous nontransformed chicken cell line that has been 
extensively used for studying transformation by avian retrovi-
ral oncogenes (50, 51). We observed that DF-1vTR cells ex-
hibited growth rates similar to those of DF-1 cells transformed 
by the MDV oncoprotein Meq, a member of the Jun/Fos 
oncoprotein family that has previously been described to ex-
hibit transforming properties (15, 19). DF-1 cells expressing 
vTR or the Meq oncoprotein grew to signifi  cantly increased 
saturation densities compared with control cells. In addition, 
we noticed that they both displayed a more refractile and 
spindle-shaped morphological phenotype and formed larger 
colony sizes in soft agar, which are common indicators for 
transformed cells. Unlike expression of Meq, expression of 
vTR exerted only a minor eff  ect on anchorage-independent 
DF-1 cell growth, but it is possible that an eff  ect of vTR was 
partially masked by the inherent potential of DF-1 cells to 
form colonies in nutrient agar (51). However, the data sup-
port the hypothesis that assigns to vTR a role in promoting 
anchorage-independent cell growth that is possibly, at least in 
part, mediated by increased levels of integrin αv. Future ex-
periments will focus on a more detailed functional character-
ization of the eff  ects of vTR in vitro and in vivo, and a 
possible cooperation of vTR and the MDV oncoprotein 
Meq in lymphoma formation and dissemination.
MATERIALS AND METHODS
MDV reconstitution and propagation. CECs were prepared from 11-d-
old specifi  c pathogen-free embryos by standard methods (28). Cells were 
maintained in DMEM supplemented with 10% FBS and grown at 37°C 
  under a 5% CO2 atmosphere. Parental vRB-1B, vTR mutant, and revertant 
viruses were generated from pRB-1B, an infectious full-length BAC clone of 
the highly oncogenic MDV strain RB-1B (23). Recombinant viruses were 
reconstituted by CaPO4 transfection of BAC DNA into CECs (28). Low-
passage virus stocks were aliquoted and frozen in liquid nitrogen until use. 
Virus propagation as well as determination of virus growth kinetics and 
plaque sizes were performed exactly as described previously (52, 53).
Red mutagenesis and Flp recombination of MDV BACs. One- or 
two-step Red mutagenesis (54, 55) was used for site-directed deletion or re-
pair of vTR in pRB-1B. Details of the performed recombinations are shown 
in Fig. S1. Escherichia coli EL250 cells (provided by N. Copeland, National 
Cancer Institute, Frederick, MD) harboring pRB-1B or its derivatives were 
used for all manipulations. Generally, 100 ng of a linear DNA was electro-
porated (1.25 kV/cm, 200 Ω, 25 μF) into 50 μl of recombination-compe-
tent cells exactly as described previously (53). For deletion of vTR, a PCR 
product comprising a kanamycin-resistance gene (kanR) fl  anked by Flp re-
combinase recognition target (FRT) sites was used. To allow subsequent re-
moval of the selectable marker by homologous recombination of the fl  anking 
FRT sites, FLP expression in EL250 cells was induced by growing bacterial 
clones for 12 h at 30°C in liquid Luria-Bertani medium containing chloram-
phenicol and 0.2% arabinose.
Previously deleted vTR sequences were reintroduced into double 
  deletion mutant pCR1-2−/− by two-step Red mutagenesis. The procedure 
was performed exactly as described recently for introduction of long 
  sequence stretches (Fig. S1 B; reference 25). A transfer cassette containing 
vTR sequences, kanR, and an I-SceI site was released from recombinant 
plasmid pCUCvTR by cleavage with I-CeuI and introduced into pCR1-2−/− 
by a fi  rst Red recombination. The insertion of the transfer cassette   resulted 
in duplication of a short sequence stretch within vTR, which was used 
to remove the resistance gene by a second Red recombination and, 
ultimately, scarless repair of authentic vTR sequences (25). Using this 
two-step (“en passant”) mutagenesis protocol, two independently gener-
ated revertant BACs were generated and termed pCR1-2−/−R1 and 
pCR1-2−/−R2, respectively.
Animal experiments. All animal experiments were approved by Cornell’s 
Institutional Animal Care and Use Committee (internal approval no. 2002-
85). 1-d-old P2a chickens (56) were inoculated by i.m. injection with 500 
PFUs of the various viruses. Mock-infected birds received an injection of 
uninfected CECs in culture medium. Experiment 1 included fi  ve groups 
(vRB-1B, vCR1-2+/−, vCR1-2−/−, vCR1-4+/−, and vCR1-2−/−) of 15 
birds as well as an additional mock-infected group. In experiments 2 and 3, 
10 and 12 birds per group, respectively, were infected. In experiment 3, 
whole blood was obtained from all birds at days 4, 7, 12, 15, 19, and 30 after 
infection by wing vein puncture to examine in vivo virus replication by 
qPCR exactly as described previously (29, 54). Experiment 4 included fi  ve 
groups (vRB-1B, vCR1-2+/−, vCR1-2−/−, vCR1-2−/−R1, and vCR1-
2−/−R2) of 12 birds per group.
Establishment of recombinant cell lines. DF-1 cells (50) were main-
tained in M199 medium supplemented with 10% FBS, 2 mM l-glutamine, 
and 2 mM sodium pyruvate and grown at 37°C under a 5% CO2 atmo-
sphere. Recombinant cell lines DF-1vector, DF-1vTR, and DF-1Meq were 
generated by transfecting expression vectors pBKCMV (Stratagene), 
  pBKCMV-vTR, or pBKCMV-Meq into DF-1 cells using lipofectamine 
(Invitrogen). pBKCMV-vTR and pBKCMV-Meq were constructed by 
cloning the respective full-length coding regions of MDV strain RB-1B into 
pBKCMV. Stable transfectants were selected and maintained by the addition 
of 300–700 μg/ml G418 (Invitrogen) to the culture medium.
Cell growth rates. To analyze cellular growth, cells of each of the recom-
binant lines were seeded in 12-well culture plates at a density of 105 per well. 
At 8, 24, 48, 72, 96, 120, and 144 h after plating, cells were dissociated by 
trypsinization, and the total number of viable cells was determined using a 
Neubauer hemocytometer under a light microscope (CK 2; Olympus). Cell 
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Soft agar colony formation assays. To analyze anchorage-independent 
cell growth in soft agar, 103–104 cells of each of the DF-1–based cell lines 
were suspended in 3 ml M199 complete and 0.35% Bacto agar and plated in 
triplicate onto a single dish of a six-well culture plate containing a 3-ml bot-
tom layer of the same medium containing 0.5% Bacto agar. Cultures were 
incubated at 37°C under a 5% CO2 atmosphere and supplemented with nu-
trient agar every 4 d. After 4 wk of incubation, colonies of >50 cells were 
counted under an inverted microscope (CK 2; Olympus). For each of the 
cell lines, 100 randomly selected colonies were photographed with a digital 
camera and colony diameters were determined using ImageJ software 
(http://rsb.info.nih.gov/ij/index.html).
Statistical analyses. All statistical calculations were performed using SAS 
v8.2 for Windows (SAS Institute). Animal experiments performed in tripli-
cate (experiments 1–3) were evaluated with nonparametric analyses, and the 
determination of globally signifi  cant diff  erences between groups was done 
using the Kruskal-Wallis test before individual comparisons of groups were 
done by pairwise testing with adjusted p-values. Fisher’s exact test was used 
to analyze animal experiment 4.
Online supplemental material. Fig. S1 shows the construction of 
vTR− and revertant MDV genomes. Fig. S2 summarizes viremia lev-
els determined in animal experiment 4 in which revertant viruses were 
compared with parental and vTR mutant viruses. Fig. S3 displays rep-
resentative gross pathological fi   ndings of chickens infected with vTR+ 
or  vTR− viruses, respectively. Stable expression of vTR and Meq in 
recombinant DF-1 cells analyzed by RT-PCR and indirect immuno-
fl  uorescence, respectively, is shown in Fig. S4, as is a Southern blot de-
termining telomere lengths. Figs. S1–S4 are available at http://www.jem.
org/cgi/content/full/jem.20052240/DC1.
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